annual meeting program - American Society of Clinical Oncology

More documents

Recommendations

Info

Monday, June 7, 2010 5:00 PM Results of a randomized, phase III trial of nab-paclitaxel (nab-P) and carboplatin (C) compared with cremophor-based paclitaxel (P) and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC). (Abstract #LBA7511) M. A. Socinski, I. N. Bondarenko, N. A. Karaseva, A. Makhson, I. Vynnichenko, I. Okamoto, J. K. Hon, V. Hirsch, P. Bhar, J. Iglesias Discussion 5:15 PM Raffit Hassan, MD (Abstract #7509–LBA7511) National Cancer Institute Optimizing Care in Advanced Lung Cancer 407 MONDAY
MONDAY Monday, June 7, 2010 3:00 PM - 6:00 PM ORAL ABSTRACT SESSION Gastrointestinal (Noncolorectal) Cancer Location: E Hall D1 CME credit: 3 Track(s): Gastrointestinal (Noncolorectal) Cancer Theodore S. Hong, MD—Co-Chair Massachusetts General Hospital Alexandria T. Phan, MD—Co-Chair University of Texas M. D. Anderson Cancer Center 3:00 PM Effect of preoperative concurrent survival of patients with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase III study. (Abstract #4004) A. V. Gaast, P. van Hagen, M. Hulshof, D. Richel, M. I. van Berge Henegouwen, G. A. Nieuwenhuijzen, J. T. Plukker, J. J. Bonenkamp, E. W. Steyerberg, H. W. Tilanus, CROSS study group 3:15 PM Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: Analysis of a randomized controlled phase III trial FFCD 9901. (Abstract #4005) C. Mariette, J. F. Seitz, E. Maillard, F. Mornex, P. a. Thomas, J. Raoul, V. Boige, D. Pezet, C. Genet, L. Bedenne, Federation Francaise de Cancerologie Digestive 3:30 PM CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer. (Abstract #4006) P. C. Enzinger, B. Burtness, D. Hollis, D. Niedzwiecki, D. Ilson, A. B. Benson, R. J. Mayer, R. M. Goldberg 3:45 PM AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC). (Abstract #LBA4007) Y. Kang, A. Ohtsu, E. Van Cutsem, S. Y. Rha, A. Sawaki, S. Park, H. Lim, J. Wu, B. Langer, M. A. Shah Discussion 4:00 PM Charles Fuchs, MD (Abstracts #4004–LBA4007) Dana-Farber Cancer Institute 4:15 PM Phase III study of oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX4) versus doxorubicin as palliative systemic chemotherapy in advanced HCC in Asian patients. (Abstract #4008) S. Qin, Y. Bai, S. Ye, J. Fan, H. Lim, J. Y. Cho, S. Thongprasert, Y. Chao, K. Rau, Y. Sun 4:30 PM Effect of IFN therapy and amino acid substitutions in the hepatitis C virus (HCV) core region on hepatocarcinogenesis in HCV-related cirrhotic patients. (Abstract #4009) M. Hirakawa, K. Ikeda, N. Akuta, Y. Kawamura, T. Hosaka, M. Kobayashi, F. Suzuki, Y. Suzuki, Y. Arase, H. Kumada Discussion 4:45 PM Timothy Pawlik, MD, MPH (Abstracts #4008–4009) The Johns Hopkins University 5:00 PM Randomized phase III trial comparing FOLFIRINOX (F: 5FU/leucovorin [LV], irinotecan [I], and oxaliplatin [O]) versus gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA): Preplanned interim analysis results of the PRODIGE 4/ACCORD 11 trial. (Abstract #4010) T. Conroy, F. Desseigne, M. Ychou, M. Ducreux, O. Bouche, R. Guimbaud, Y. Becouarn, C. Montoto-Grillot, S. Gourgou-Bourgade, A. Adenis, FNCLCC-FFCD PRODIGE Group 408
Page 1 and 2:
46th Annual Meeting June 4-8, 2010
Page 3 and 4:
SESSIONS AND SYMPOSIA SCIENTIFIC SE
Page 5 and 6:
SESSIONS AND SYMPOSIA continued SPE
Page 7 and 8:
ANNUAL MEETING PLANNING COMMITTEES
Page 9 and 10:
ANNUAL MEETING PLANNING COMMITTEES
Page 11 and 12:
CONTINUING MEDICAL EDUCATION INFORM
Page 13 and 14:
ONSITE DETAILS continued floor plan
Page 15 and 16:
ASCO SHUTTLE SERVICE Complimentary
Page 17 and 18:
POLICIES Important Security and Att
Page 19 and 20:
AWARDS continued 2010 Merit Awards
Page 21 and 22:
AWARDS continued 2010 Advanced Clin
Page 23 and 24:
AWARDS continued 2010 International
Page 25 and 26:
AWARDS continued 2006 YIA Paul Halu
Page 27 and 28:
2010 ANNUAL MEETING SUPPORTERS* THE
Page 29 and 30:
2010 ANNUAL MEETING SUPPORTERS cont
Page 31 and 32:
PROGRAM BY TRACK Breast Cancer cont
Page 33 and 34:
PROGRAM BY TRACK Central Nervous Sy
Page 35 and 36:
PROGRAM BY TRACK Developmental Ther
Page 37 and 38:
PROGRAM BY TRACK Gastrointestinal (
Page 39 and 40:
PROGRAM BY TRACK Genitourinary Canc
Page 41 and 42:
PROGRAM BY TRACK Gynecologic Cancer
Page 43 and 44:
PROGRAM BY TRACK International cont
Page 45 and 46:
PROGRAM BY TRACK Lymphoma and Plasm
Page 47 and 48:
PROGRAM BY TRACK Patient and Surviv
Page 49 and 50:
PROGRAM BY TRACK Pediatric Oncology
Page 51 and 52:
PROGRAM BY TRACK Professional Devel
Page 53 and 54:
PROGRAM BY TRACK Special Sessions c
Page 55 and 56:
FRIDAY Friday, June 4, 2010 1:00 PM
Page 57 and 58:
Page 59 and 60:
FRIDAY Friday, June 4, 2010 Sex and
Page 61 and 62:
Page 63 and 64:
FRIDAY Friday, June 4, 2010 Brd. 7
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
SATURDAY Saturday, June 5, 2010 7:3
Page 81 and 82:
SATURDAY Saturday, June 5, 2010 Mel
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
SATURDAY Saturday, June 5, 2010 Brd
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
SATURDAY Saturday, June 5, 2010 Dis
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
SATURDAY Saturday, June 5, 2010 Imp
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
SUNDAY Sunday, June 6, 2010 7:30 AM
Page 191 and 192:
Page 193 and 194:
SUNDAY Sunday, June 6, 2010 PARP In
Page 195 and 196:
Page 197 and 198:
SUNDAY Sunday, June 6, 2010 Brd. 2D
Page 199 and 200:
SUNDAY Sunday, June 6, 2010 Brd. 5F
Page 201 and 202:
Page 203 and 204:
SUNDAY Sunday, June 6, 2010 Brd. 13
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
SUNDAY Sunday, June 6, 2010 Discuss
Page 231 and 232:
SUNDAY Sunday, June 6, 2010 Discuss
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
SUNDAY Sunday, June 6, 2010 10:30 A
Page 243 and 244:
SUNDAY Sunday, June 6, 2010 11:30 A
Page 245 and 246:
SUNDAY Sunday, June 6, 2010 1:00 PM
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
SUNDAY Sunday, June 6, 2010 Brd. 3G
Page 259 and 260:
SUNDAY Sunday, June 6, 2010 Brd. 6F
Page 261 and 262:
SUNDAY Sunday, June 6, 2010 Brd. 9G
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
SUNDAY Sunday, June 6, 2010 The Evo
Page 291 and 292:
MONDAY Monday, June 7, 2010 7:30 AM
Page 293 and 294:
Page 295 and 296:
MONDAY Monday, June 7, 2010 The Bio
Page 297 and 298:
Page 299 and 300:
MONDAY Monday, June 7, 2010 Brd. 7
Page 301 and 302:
MONDAY Monday, June 7, 2010 Brd. 2D
Page 303 and 304:
MONDAY Monday, June 7, 2010 Brd. 5E
Page 305 and 306:
MONDAY Monday, June 7, 2010 Brd. 8F
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
MONDAY Monday, June 7, 2010 TRIALS
Page 315 and 316:
MONDAY Monday, June 7, 2010 Breast
Page 317 and 318:
MONDAY Monday, June 7, 2010 Central
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
MONDAY Monday, June 7, 2010 11:45 A
Page 347 and 348:
MONDAY Monday, June 7, 2010 11:45 A
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356: MONDAY Monday, June 7, 2010 11:30 A
Page 357 and 358: MONDAY Monday, June 7, 2010 Discuss
Page 359 and 360: MONDAY Monday, June 7, 2010 Brd. 2F
Page 361 and 362: MONDAY Monday, June 7, 2010 Brd. 5G
Page 363 and 364: MONDAY Monday, June 7, 2010 Brd. 9A
Page 365 and 366: MONDAY Monday, June 7, 2010 Brd. 13
Page 377 and 378: MONDAY Monday, June 7, 2010 1:00 PM
Page 389 and 390: MONDAY Monday, June 7, 2010 NCI Com
Page 405: MONDAY Monday, June 7, 2010 3:00 PM
Page 415 and 416: TUESDAY Tuesday, June 8, 2010 7:30
Page 417 and 418: TUESDAY Tuesday, June 8, 2010 Early
Page 421 and 422: TUESDAY Tuesday, June 8, 2010 Brd.
show all

annual meeting program - American Society of Clinical Oncology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?